IRWD Q2 2017 Earnings — Ironwood Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

IRWDIronwood Pharmaceuticals, Inc.

$603M

Q2 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$65M+19.7% YoY

Gross Profit

$62M94.6% margin

Operating Income

-$41M-63.0% margin

Net Income

-$44M-68.0% margin

EPS (Diluted)

$-0.30

QoQ Revenue Growth

+24.7%

Cash Flow

Operating Cash Flow

-$31M

Free Cash Flow

-$32M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$705M

Total Liabilities

$700M

Stockholders' Equity

$5M

Cash & Equivalents

$182M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$65M	$54M	+19.7%
Gross Profit	$62M	$23M	+171.6%
Operating Income	-$41M	-$15M	-167.8%
Net Income	-$44M	-$22M	-103.8%